Anti-PD1-antibody and Pulsed HHI for Advanced BCC

NCT04679480 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Basal Cell Carcinoma

Interventions

DRUG: Cemiplimab Injection [Libtayo]

Sponsor

Reinhard Dummer

Collaborators

[object Object]
[object Object]